🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial

Jonathan Ledermann, Philipp Harter et al. (2014)

The Lancet Oncology

1.3K citesjournal articlePDF

Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma

John F. Toso, Vee J. Gill et al. (2002)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer

A. Gennari, F. André et al. (2021)

Annals of Oncology

1.4K citesjournal articlePDF

Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

Klaus Maier-Hauff, Frank Ulrich et al. (2010)

Journal of Neuro-Oncology

1.3K citesjournal articlePDF

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

Nigel S. Key, Alok A. Khorana et al. (2020)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A Tawbi, Melissa Burgess et al. (2017)

The Lancet Oncology

1.3K citesjournal articlePDF

Big data and machine learning algorithms for health-care delivery

Kee Yuan Ngiam, Ing Wei Khor (2019)

The Lancet Oncology

1.3K citesjournal articlePDF

Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

F. Lordick, F. Carneiro et al. (2022)

Annals of Oncology

1.5K citesjournal articlePDF

Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab

Jeffrey S. Weber, Katharina C. Kähler et al. (2012)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer

Graeme J.K. Guthrie, Kellie A. Charles et al. (2013)

Critical Reviews in Oncology/Hematology

1.3K citesjournal articlePDF

Matrix Metalloproteinases: Biologic Activity and Clinical Implications

Amy R. Nelson, Barbara Fingleton et al. (2000)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study

Charles W. Whitney, William Sause et al. (1999)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

Frank Stephen Hodi, Vanna Chiarion-Sileni et al. (2018)

The Lancet Oncology

1.3K citesjournal articlePDF

Karnofsky performance status revisited: reliability, validity, and guidelines.

C C Schag, R L Heinrich et al. (1984)

Journal of Clinical Oncology

1.3K citesjournal articlePDF

Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis

Fred R. Hirsch, Marileila Varella-Garcia et al. (2003)

Journal of Clinical Oncology

1.2K citesjournal articlePDF